Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2026-04-03 21:00:04 ET · period of report 2026-04-01 · accession 0001193125-26-142647 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-03 21:00 | 2026-04-01 | TMCI | Hair Mark | CFO | A - Grant | $0.00 | +100.0K | 963.5K | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-01 | A | A | 100,000 | $0.00 | 963,549 | D | — | — | (F1) Represents performance stock units ("PSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each PSU upon vesting. The PSUs were earned upon the Compensation Committee's certification of accomplishment of a performance goal and will vest 25% on April 15, 2026 and 25% on each February 15 of 2027, 2028, and 2029, subject to the Reporting Person's continued service through the applicable vesting date. (F2) Includes 811,691 restricted stock units. |